Cash drought leads to Inion AIM de-listing; mulls closing doors
This article was originally published in Clinica
Executive Summary
In a bid to conserve cash reserves, manufacturer of biodegradable medical implants Inion has set a timetable for de-listing from the London Stock Exchange’s Alternative Investment Market (AIM).